Biopharma PEG announces a groundbreaking array of monodispersed PEGs to propel the pharma industry into a new era.
Huateng Pharma has unveiled a suite of advanced anti-diabetes intermediates, featuring compounds intricately designed to target diabetes with unprecedented precision.
The merger between Bora Health and Sunway Biotech marks the dawn of a transformative era in nutraceutical innovation.
From its inception, SAI has prioritized the development of core capabilities in chemistry.
FDA feedback indicates that Precision Biosciences’Â shared CMC plans are compliant with Agency expectations.
With 146 billion won, Daewoong Bio intends to enter the contract development and manufacturing organization (CDMO) market.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings
